Segment Information (Tables)

3 Months Ended

Sep. 30, 2021

Segment Reporting, Revenue Reconciling Item [Line Items]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following table presents revenue by geographic area:

	Three Months Ended September 30,
(in millions)	2021		2020
United States	$	42,841	$	37,976
International	1,130		1,093
Total segment revenue	43,971		39,069
Corporate (1)	(3)		(4)
Total revenue	$	43,968	$	39,065

(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:

	Three Months Ended September 30,
(in millions)	2021		2020
Pharmaceutical Distribution and Specialty Solutions (1) (2)	$	39,614	$	34,916
Nuclear and Precision Health Solutions	208		196
Pharmaceutical segment revenue	39,822		35,112
Medical distribution and products (3)	3,567		3,438
Cardinal Health at-Home Solutions	582		519
Medical segment revenue	4,149		3,957
Total segment revenue	43,971		39,069
Corporate (4)	(3)		(4)
Total revenue	$	43,968	$	39,065

(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services".

(2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.

(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.

(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

The following table presents segment profit by reportable segment and Corporate:

	Three Months Ended September 30,
(in millions)	2021		2020
Pharmaceutical	$	406	$	402
Medical	123		230
Total segment profit	529		632
Corporate	(114)		(1,256)
Total operating earnings/(loss)	$	415	$	(624)

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	September 30, 2021		June 30, 2021
Pharmaceutical	$	23,955	$	23,624
Medical (1)	14,156		15,408
Corporate	4,882		5,421
Total assets	$	42,993	$	44,453

(1) Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June 30, 2021.